BACKGROUND: Infection with cytomegalovirus (CMV) remains a potentially serious complication in transplant patients. In this study we explored the risk factors for CMV infection in the 12 months following a solid organ transplantation (n = 242) in patients monitored for CMV infection from 2004 to 2007. METHODS: CMV infection was defined as 2 consecutive quantifiable CMV-polymerase chain reaction (PCR) values or 1 measurement of >3000 copies/ml. Data describing pre- and post-transplantation variables were extracted from electronic health records. Time to CMV infection was investigated using Cox proportional hazards analysis. RESULTS: Overall, 31% (75/242) of solid organ transplant patients developed CMV infection: 4/8 (50.0%) heart, 15/43 (34.9%) liver, 30/89 (33.7%) lung and 26/102 (25.5%) kidney transplant patients. The risk of CMV infection according to donor (D)/recipient (R) CMV serostatus (positive + or negative-) was highest for D+/R-(adjusted hazard ratio 2.6, 95% confidence interval 1.6-4.2) vs D+/R+, and was reduced for D-/R+(adjusted hazard ratio 0.2, 95% confidence interval 0.2-0.8) vs D+/R+. CONCLUSION: Positive donor CMV-serostatus is a major risk factor for CMV-infection in CMV-na ve recipients, but also in recipients with positive CMV-serostatus. Conversely, if donor is CMV serostatus is negative, the risk of CMV infection is low, irrespective of recipients CMV-serostatus. These findings suggest poorer immune function towards donor-induced strains of CMV versus recipient own latent strains.
BACKGROUND: Infection with cytomegalovirus (CMV) remains a potentially serious complication in transplant patients. In this study we explored the risk factors for CMV infection in the 12 months following a solid organ transplantation (n = 242) in patients monitored for CMV infection from 2004 to 2007. METHODS:CMV infection was defined as 2 consecutive quantifiable CMV-polymerase chain reaction (PCR) values or 1 measurement of >3000 copies/ml. Data describing pre- and post-transplantation variables were extracted from electronic health records. Time to CMV infection was investigated using Cox proportional hazards analysis. RESULTS: Overall, 31% (75/242) of solid organ transplant patients developed CMV infection: 4/8 (50.0%) heart, 15/43 (34.9%) liver, 30/89 (33.7%) lung and 26/102 (25.5%) kidney transplant patients. The risk of CMV infection according to donor (D)/recipient (R) CMV serostatus (positive + or negative-) was highest for D+/R-(adjusted hazard ratio 2.6, 95% confidence interval 1.6-4.2) vs D+/R+, and was reduced for D-/R+(adjusted hazard ratio 0.2, 95% confidence interval 0.2-0.8) vs D+/R+. CONCLUSION: Positive donor CMV-serostatus is a major risk factor for CMV-infection in CMV-na ve recipients, but also in recipients with positive CMV-serostatus. Conversely, if donor is CMV serostatus is negative, the risk of CMV infection is low, irrespective of recipients CMV-serostatus. These findings suggest poorer immune function towards donor-induced strains of CMV versus recipient own latent strains.
Authors: C Ekenberg; I P Lodding; N E Wareham; S S Sørensen; H Sengeløv; F Gustafsson; A Rasmussen; M Perch; J D Lundgren; M Helleberg Journal: Eur J Clin Microbiol Infect Dis Date: 2017-08-08 Impact factor: 3.267
Authors: Isabelle P Lodding; Amanda Mocroft; Caspar da Cunha Bang; Finn Gustafsson; Martin Iversen; Nikolai Kirkby; Michael Perch; Allan Rasmussen; Henrik Sengeløv; Søren S Sørensen; Jens D Lundgren Journal: Transplant Direct Date: 2018-05-16
Authors: Isabelle P Lodding; Mette Jørgensen; Marc Bennedbæk; Nikolai Kirkby; Klaudia Naegele; Finn Gustafsson; Michael Perch; Allan Rasmussen; Henrik Sengeløv; Søren S Sørensen; Hans H Hirsch; Jens D Lundgren Journal: Open Forum Infect Dis Date: 2021-09-04 Impact factor: 3.835
Authors: I P Lodding; H Sengeløv; C da Cunha-Bang; M Iversen; A Rasmussen; F Gustafsson; J G Downing; J Grarup; N Kirkby; C M Frederiksen; A Mocroft; S S Sørensen; J D Lundgren Journal: EBioMedicine Date: 2015-05-08 Impact factor: 8.143
Authors: I P Lodding; C da Cunha Bang; S S Sørensen; F Gustafsson; M Iversen; N Kirkby; M Perch; A Rasmussen; H Sengeløv; A Mocroft; J D Lundgren Journal: Open Forum Infect Dis Date: 2018-04-17 Impact factor: 3.835